USANA Health Sciences(NYSE:USNA) announced the earnings results for Fiscal Year 2016 and Q2. The results came in during After-hours on Jul 26, 2016. Company reported revenue of $258.51M. Analysts estimated a revenue of $256.66M. Earnings per share were $2.07. Analysts had estimated an EPS of $2.05.
USANA Health Sciences (USNA) made into the market gainers list on Fridays trading session with the shares advancing 0.13% or 0.18 points. Due to strong positive momentum, the stock ended at $137.32, which is also near the day’s high of $138.57. The stock began the session at $137.31 and the volume stood at 1,19,061 shares. The 52-week high of the shares is $176.88 and the 52 week low is $92.001. The company has a current market capitalization of $1,644 M and it has 1,19,71,998 shares in outstanding.
Several Insider Transactions has been reported to the SEC. On Jul 15, 2016, Myron W Wentz (director) sold 10,000 shares at $118.96 per share price.Also, On Jul 15, 2016, Global Ltd Gull (10% owner) sold 10,000 shares at $118.96 per share price.On Jun 7, 2016, Dave Wentz (Co-C.E.O.) sold 10,000 shares at $125.04 per share price, according to the Form-4 filing with the securities and exchange commission.
USANA Health Sciences Inc. develops and manufactures science-based nutritional and personal care products. The Company has operations in approximately 19 markets across the world where it distributes and sells its products by way of direct selling. The Company operates as a direct selling company and reports revenue in two geographic regions: Americas and Europe and Asia Pacific which includes three sub-regions as: Southeast Asia Pacific Greater China and North Asia. Americas and Europe includes the United States Canada Mexico Colombia the United Kingdom France Belgium and the Netherlands. Southeast Asia Pacific includes Australia New Zealand Singapore Malaysia the Philippines and Thailand; Greater China includes Hong Kong Taiwan and China and North Asia includes Japan and South Korea.